Yozo Kawano
- Molecular Biology
- Oncology top 10%
- Cancer Research top 5%
- Pulmonary and Respiratory Medicine top 10%
- Immunology
- Co-authors
- Hiromi WadaFumihiro TanakaRyo MiyaharaKazuhiro YanagiharaYosuke OtakeMio LiShinya IshikawaTatsuo Nakagawa
- Topics
- Lung Cancer Diagnosis and Treatment (6 papers)Lung Cancer Treatments and Mutations (6 papers)Angiogenesis and VEGF in Cancer (5 papers)
In The Last Decade
Yozo Kawano
26 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 87
- Molecular Biology 657
- Oncology 435
- Cancer Research 362
- Pulmonary and Respiratory Medicine 331
- Immunology 124
Countries citing papers authored by Yozo Kawano
This map shows the geographic impact of Yozo Kawano's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yozo Kawano with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yozo Kawano more than expected).
Fields of papers citing papers by Yozo Kawano
This network shows the impact of papers produced by Yozo Kawano. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yozo Kawano. The network helps show where Yozo Kawano may publish in the future.
Co-authorship network of co-authors of Yozo Kawano
This figure shows the co-authorship network connecting the top 25 collaborators of Yozo Kawano. A scholar is included among the top collaborators of Yozo Kawano based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yozo Kawano. Yozo Kawano is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 41 | |
| 2 | DYRK2 expression may be a predictive marker for chemotherapy in non-small cell lung cancer. | 30 |
| 3 | 12 | |
| 4 | 27 | |
| 5 | 27 | |
| 6 | 28 | |
| 7 | 30 | |
| 8 | 2 | |
| 9 | 18 | |
| 10 | 88 | |
| 11 | 39 | |
| 12 | 6 | |
| 13 | 36 | |
| 14 | 86 | |
| 15 | 38 | |
| 16 | 9 | |
| 17 | Evaluation of angiogenesis in non-small cell lung cancer: comparison between anti-CD34 antibody and anti-CD105 antibody. | 226 |
| 18 | Expression of polysialic acid and STX, a human polysialyltransferase, is correlated with tumor progression in non-small cell lung cancer. | 113 |
| 19 | 45 | |
| 20 | 0 |
About Yozo Kawano
Yozo Kawano is a scholar working on Microbiology, Cancer Research and Pulmonary and Respiratory Medicine, having authored 28 papers that have together received 1.2k indexed citations. Recurring topics across this work include Lung Cancer Diagnosis and Treatment (6 papers), Lung Cancer Treatments and Mutations (6 papers) and Angiogenesis and VEGF in Cancer (5 papers). The work is most often cited by research in Cancer Research (362 citations), Oncology (435 citations) and Immunology and Allergy (82 citations). Yozo Kawano has collaborated with scholars based in Japan and France. Frequent co-authors include Hiromi Wada, Fumihiro Tanaka, Ryo Miyahara, Kazuhiro Yanagihara, Yosuke Otake, Mio Li, Shinya Ishikawa, Tatsuo Nakagawa, Nobuharu Hanaoka and Kazumasa Takenaka. Their work appears in journals such as Journal of Clinical Oncology, Clinical Cancer Research and International Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.